r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

LK

Lawrence Otto Klein

Insider · Chief Executive Officer · ORKA

Lawrence Otto Klein files insider transactions with the SEC as a chief executive officer of Oruka Therapeutics (ORKA). We hold 3 disclosed purchases and sales filed since 3 January 2019, 2 of them in the last 90 days.

  • Files forORKA
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure1 September 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 22 January 2025 — 1 September 2026Chief Executive Officer · Oruka Therapeutics (ORKA)13 Form 4 lines · source: SEC Form 4
  • Filed 29 April 2025 — 9 June 2026Director · Jade Biosciences (JBIO)2 Form 4 lines · source: SEC Form 4
  • Filed 21 March 2022 — 7 June 2023Director · Jasper Therapeutics (JSPR)3 Form 4 lines · source: SEC Form 4
  • Filed 2 January 2019 — 16 August 2022Cbo & COO · CRISPR Therapeutics AG (CRSP)85 Form 4 lines · source: SEC Form 4
  • Filed 31 July 2020 — 5 July 2022Director · Dyne Therapeutics (DYN)8 Form 4 lines · source: SEC Form 4

Everything they disclosed

111 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.